We are TPIRC

Translational
Pulmonary & Immunology
Research Center

about us

TPIRC is a non-profit research and clinical care center that focuses on the development of cutting-edge, individualized treatment protocols for orphan diseases utilizing comprehensive diagnostic tools and patient-driven research.

a data-driven approach

TPIRC was established in 2015 by Dr. Inderpal Randhawa. Early in his career, Dr. Randhawa began to question conventional protocols for the treatment of life-threatening food allergies. By studying a vast number of genetic and environmental factors, he developed a comprehensive, multi-system approach resulting in individualized, data-driven treatment regimens for allergic patients.
Over the past 10 years, Dr. Randhawa has successfully treated thousands of patients at a near-perfect success rate utilizing this model, offering food-allergic children and young adults the freedom to safely eat foods to which they were once severely allergic. This unprecedented model of success led him to found TPIRC, an unconventional clinic and research center where precision medicine and data-analytics drive the treatment of not only food allergies, but also a series of orphan diseases.

unmasking millions of data points

Although the hallmark of TPIRC's clinic is the individualized, precision medicine approach to patient care, the beauty of this methodology is that with each case that we treat, we collectively unmask millions of data points relating to the care of some of the most challenging diseases. This form of data collection and analysis opens the door for truly patient-driven research derived from real-world, clinical outcomes rather than laboratory hypotheses. Like the diseases we seek to eradicate, the analysis of this data is both intricate and difficult, however, this collection of shared information offers the greatest hope to truly advance treatment protocols for some of the most complex conditions.
The TPIRC model is already offering cutting-edge treatments and exceptional advancements in care across our five primary areas of focus: food allergy, cystic fibrosis, bronchiectasis, airway inflammatory disorders, and immunodeficiency. Our proven track record of success is characterized by transparency and accountability, offering our patients and their families, as well as our supporters, the opportunity to partner with us to significantly better their own health while opening doors to radically improve the way medical research and care take place.

TPIRC Research Center

Our mission is two-fold: to advance treatment discovery at a pace which helps our patients today while building a scalable model of success to accelerate the rate of research discovery for all diseases.

Restoring Hope

Advancing Discovery

Empowering Communities

the story behind the butterfly

The TPIRC butterfly logo represents the hope our institute offers to orphan diseases. Lifting up this butterfly are wings representing lungs composed of many smaller circular segments. The lungs are the most critical organ to live. The lungs are composed of many vital connections to other areas of the body's composition of health. Each circle exemplifies important disease areas that affect human health.
TPIRC is organized around a complete and comprehensive analysis of numerous data points studying many of these critical connections which yield health. TPIRC's model of disease research, discovery and therapy is not limited to any one disease. However, the butterfly's wings are highlighted by five blue circles representing Dr. Randhawa's sentinel interests: food anaphylaxis, bronchiectasis, cystic fibrosis, immune deficiency and airway inflammatory disorders. TPIRC's success in an array of diseases reflects its ultimate goal — to leave no disease behind.

Our Founder